The UK is experiencing tightening supplies of epidural infusions after a key supplier’s contract expired and demand increased for the anesthetic commonly used by women giving birth.

The UN agency that responds to Ebola outbreaks and other health emergencies is in turmoil. But its leaders say it could emerge stronger.

Pascal Soriot has turned the drugmaker into an oncology powerhouse with a high-pressure culture and a deep relationship with the US.

For decades, men with the disease faced a binary choice: live with the cancer, or live with the consequences of removing it. This doctor is pushing an alternative that he says is more precise, humane ...

Johnson & Johnson is withdrawing a device to treat debilitating acid reflux disease from markets outside the US, a move surgeons warned would set back the available treatment options for sufferers...

Demand for Novo Nordisk A/S’s weight-loss blockbuster Wegovy is getting a boost in the UK from an unexpected corner: arch-rival Eli Lilly & Co.

Part one: How the Trump Administration abandoned orphans with HIV

Spain ranks first in Europe for clinical trials and is attracting investment in life sciences, but faces intense competition including from China.

The head of the global organization responsible for vaccinating children in the world’s poorest countries is headed to Washington, hoping to persuade the Trump administration to reverse a surprise dec...

The World Health Organization is asking some employees to consider early retirement as the United Nations agency seeks to cut costs following US President Donald Trump’s decision to withdraw.

The World Health Organization is asking some employees to consider early retirement as the United Nations agency seeks to cut costs following US President Donald Trump’s decision to withdraw.

Trump’s overhaul of the CDC has scientists worried about flu, measles and even Ebola.

AI drug developer Recursion Pharmaceuticals Inc. is considering an Amazon Prime-style subscription model for selling its pipeline of medicines.

As of December, more than 7.4 million cases were still on waiting lists.

Financing for global health has never looked more dire as the world reels from US President Donald Donald Trump’s dramatic pullback. Now the biggest funder of programs against HIV, tuberculosis and ma...

The two most senior executives at the World Health Organization have hit back at decisions by President Donald Trump to withdraw from the global health agency and suspend US foreign aid.

The World Health Organization called on the US to reconsider President Donald Trump’s decision to exit the agency, suggesting the move could undermine global health security.

The medicines pricing regulator, pharmaceutical companies and government are locked in a row over access to life-extending therapies.